Leukopenia clinical trials

Explore recruiting leukopenia clinical trials.

Recruiting leukopenia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Leukopenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective study to evaluate the efficacy of letermovir prophylaxis for the prevention of CMV infection in lung transplant recipients compared to a retrospective cohort treated with standard valganciclovir prophylaxis for 12 months (LETERCOR Study)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Cytomegalovirus Prophylaxis with Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study

Slovenia

Therapeutic exploratory (Phase II) EU CTIS Study details

Anti-CD19 CAR T-Cell TherApy in Refractory Systemic Autoimmune DISeases - CATARSIS

Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized multicenter clinical trial in patients with primary resectable esophageal carcinoma (cT1-4, N0-3, M0)

Belgium, Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects with Chronic Lymphocytic Leukemia

Norway, Sweden, Denmark, Spain, Netherlands, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

E-merge - Evaluation of MEpolizumab-based regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic Granulomatosis With Polyangiitis. Prospective, randomized, controlled, double-blind study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Leukopenia trials by city

Leukopenia in Toronto Leukopenia in Vancouver Leukopenia in Montreal Leukopenia in Calgary Leukopenia in Edmonton Leukopenia in Ottawa Leukopenia in Winnipeg Leukopenia in Quebec City Leukopenia in Hamilton Leukopenia in Kitchener Leukopenia in London Leukopenia in Halifax Leukopenia in New York Leukopenia in Los Angeles Leukopenia in Chicago Leukopenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease